Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 1813 of 3330
Next
>>
>
45301 to 45325 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
MCF12A	NM	Basal B	LBH589	HDAC	HDAC	0.0107	uM	10817.154	0.9761	0.9670	1.4551
MCF12A	NM	Basal B	LBH589	HDAC	HDAC	0.0533	uM	10817.154	1.0417	1.0569	1.4551
MCF12A	NM	Basal B	LBH589	HDAC	HDAC	0.267	uM	10817.154	0.9996	0.9994	1.4551
MCF12A	NM	Basal B	LBH589	HDAC	HDAC	1.33	uM	10817.154	0.2967	-0.1323	1.4551
MCF12A	NM	Basal B	LBH589	HDAC	HDAC	6.67	uM	10817.154	0.0194	-0.8667	1.4551
MCF12A	NM	Basal B	LBH589	HDAC	HDAC	33.3	uM	10817.154	0.0180	-0.8736	1.4551
MCF12A	NM	Basal B	LBH589	HDAC	HDAC	0.0000853	uM	12365.167	0.9877	0.9878	2.0273
MCF12A	NM	Basal B	LBH589	HDAC	HDAC	0.000427	uM	12365.167	1.0326	1.0319	2.0273
MCF12A	NM	Basal B	LBH589	HDAC	HDAC	0.00213	uM	12365.167	0.9865	0.9867	2.0273
MCF12A	NM	Basal B	LBH589	HDAC	HDAC	0.0107	uM	12365.167	1.0037	1.0036	2.0273
MCF12A	NM	Basal B	LBH589	HDAC	HDAC	0.0533	uM	12365.167	0.8326	0.8271	2.0273
MCF12A	NM	Basal B	LBH589	HDAC	HDAC	0.267	uM	12365.167	0.5030	0.4250	2.0273
MCF12A	NM	Basal B	LBH589	HDAC	HDAC	1.33	uM	12365.167	0.1855	-0.1288	2.0273
MCF12A	NM	Basal B	LBH589	HDAC	HDAC	6.67	uM	12365.167	0.0574	-0.5116	2.0273
MCF12A	NM	Basal B	LBH589	HDAC	HDAC	33.3	uM	12365.167	0.0320	-0.6338	2.0273
MCF7	HR+	Luminal	LBH589	HDAC	HDAC	0.0000853	uM	10997.154	0.9937	0.9886	1.0978
MCF7	HR+	Luminal	LBH589	HDAC	HDAC	0.000427	uM	10997.154	1.0127	1.0232	1.0978
MCF7	HR+	Luminal	LBH589	HDAC	HDAC	0.00213	uM	10997.154	1.0458	1.0832	1.0978
MCF7	HR+	Luminal	LBH589	HDAC	HDAC	0.0107	uM	10997.154	1.0082	1.0149	1.0978
MCF7	HR+	Luminal	LBH589	HDAC	HDAC	0.0533	uM	10997.154	0.8154	0.6608	1.0978
MCF7	HR+	Luminal	LBH589	HDAC	HDAC	0.267	uM	10997.154	0.3014	-0.3293	1.0978
MCF7	HR+	Luminal	LBH589	HDAC	HDAC	1.33	uM	10997.154	0.0674	-0.8285	1.0978
MCF7	HR+	Luminal	LBH589	HDAC	HDAC	6.67	uM	10997.154	0.0403	-0.8926	1.0978
MCF7	HR+	Luminal	LBH589	HDAC	HDAC	33.3	uM	10997.154	0.0205	-0.9419	1.0978
MDA-MB-134-VI	HR+	Luminal	LBH589	HDAC	HDAC	0.0000853	uM	10998.154	0.9982	0.9953	0.7412

|<
<<
Previous
Page 1813 of 3330
Next
>>
>
45301 to 45325 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)